Chile vs Iraq: Cocaine use disorder death rate
Chile
0.08 deaths per 100,000 people
in 2021
Iraq
0.08 deaths per 100,000 people
in 2021
Chile rank
50th
Iraq rank
50th
Cocaine use disorder death rate over time
- Chile
- Iraq
How they compare
Chile currently reports 0.08 deaths per 100,000 people against 0.08 deaths per 100,000 people in Iraq, a difference of 0 deaths per 100,000 people.
Across all 22 years both countries report, Iraq has been ahead every year.
Chile ranks 50th and Iraq ranks 50th of 194 countries.
Iraq has averaged higher in every one of the 3 decades both report.
Head to head by decade
| Decade | Chile | Iraq | Difference | Ahead |
|---|---|---|---|---|
| 2000s | 0.02 deaths per 100,000 people | 0.102 deaths per 100,000 people | 0.082 deaths per 100,000 people | Iraq |
| 2010s | 0.03 deaths per 100,000 people | 0.084 deaths per 100,000 people | 0.054 deaths per 100,000 people | Iraq |
| 2020s | 0.06 deaths per 100,000 people | 0.075 deaths per 100,000 people | 0.015 deaths per 100,000 people | Iraq |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher cocaine use disorder death rate, Chile or Iraq?
- Chile, at 0.08 deaths per 100,000 people against 0.08 deaths per 100,000 people in Iraq as of 2021.
- What is the difference in cocaine use disorder death rate between Chile and Iraq?
- 0 deaths per 100,000 people, with Chile ahead.
- How many years of comparable data are there for Chile and Iraq?
- 22 years are reported by both, from 2000 to 2021.
- How do Chile and Iraq rank globally for cocaine use disorder death rate?
- Chile ranks 50th and Iraq ranks 50th of 194 countries.
- Where does this data come from?
- World Health Organization (2024) – with major processing by Our World in Data, published as Cocaine use disorder death rate. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Estimated number of deaths from cocaine use disorders in both sexes, per 100,000 people.